Steps towards a Multiple Myeloma Cure?
Alessandro GozzettiMonica BocchiaPublished in: Journal of personalized medicine (2022)
Multiple myeloma survival has increased in last 20 years because of new treatments, better clinical management due to novel diagnostic tools such as imaging, and better understanding of the disease, biologically and genetically. Novel drugs have been introduced that act with different therapeutic mechanisms, but so have novel therapeutic strategies such as consolidation and maintenance after autologous stem cell transplant. Imaging (such as PET-CT and MRI) has been applied at diagnosis and after therapy for minimal residual disease monitoring. Multiparametric flow and molecular NGS may detect, with high-sensitivity, residual monoclonal plasma cells in the bone marrow. With this novel therapeutic and biological approach, a considerable fraction of multiple myeloma patients can achieve durable remission or even MGUS-like regression, which can ultimately lead to disease disappearance. The big dogma, "Myeloma is an incurable disease", is hopefully fading.
Keyphrases
- multiple myeloma
- pet ct
- bone marrow
- stem cells
- high resolution
- end stage renal disease
- newly diagnosed
- induced apoptosis
- chronic kidney disease
- magnetic resonance imaging
- mesenchymal stem cells
- peritoneal dialysis
- cell therapy
- systemic lupus erythematosus
- magnetic resonance
- prognostic factors
- big data
- disease activity
- mass spectrometry
- cell death
- contrast enhanced
- free survival
- single molecule
- ulcerative colitis